< 回列表
Prof. Lim Chwee Ming
- Head, Senior Consultant, Department of Otolaryngology-Head and Neck Surgery, Singapore General Hospital
- Associate Professor, Duke-NUS Medical School
- Director, Department of Clinical Translational Research, Singapore General Hospital
Translational tumor microenvironment to cellular therapeutics in Nasopharyngeal Cancer.
| 角色 | 講師 |
| 日期時間 | 05/02 15:15 - 16:05 |
| 地點 | 701F |
學歷 / 訓練
1998, MBBS, National University of Singapore
2003, MRCS(Edin), Royal College of Surgeons (Edinburgh)
2006, Masters of Medicine (Otolaryngology), NUS
2009, FAMS, College of Surgeons Academy of Medicine
2012, Advanced Head and Neck Surgical Oncology , University of Pittsburgh
專業與研究經歷
2025 - Present, Vice President, Robotic Surgery Society of Singapore
2015 - Present, Member, International Guild of Robotic and Endoscopic Head and Neck Surgery
2014 - Present, Member, Asian Society of Head & Neck Oncology
2014 - Present, Executive Board Member and council Member, Asia Pacific Society of Thyroid Surgery
2012 - Present, Member, Singapore Society of Otolaryngology – Head & Neck Surgery
獲獎與榮譽
2025
Senior Clinician Scientist Award (National Medical Research Council)
2024
Top 2% Most-cited Scientists in 2024 (Single impact, Clarivate)
2024
27th YAHYA COHEN MEMORIAL LECTURESHIP (College of Surgeons Academy of Medicine, Singapore)
2022
Singhealth Outstanding Researcher Award
2017
Best Cancer team Science award (Interstellar Initiative Joint New York Science Academy)
重要出版品
- E Elaine Y F Huang, Nern Hoong Kao, Snow Yunni Lin, Isabelle J H Jang, Kimberley Liqin Kiong, Elaine Lim. Anna See, Nanda Venkatanarasimha, Kristen Alexa Lee, Chwee Ming Lim. Concordance of the ACR TI-RADS Classification With Bethesda Scoring and Histopathology Risk Stratification of Thyroid Nodules. JAMA Network Open, 2023 September 5, 2023; 6(9):e2331612. doi: 10.1001/jamanetworkopen.2023.31612. PMID: 37703017 Impact factor: 13.353
- Lim CM, Liou A, Poon M, Liang PK, Tan LK, Loh KS, Petersson BF, Ting E, Campana D, Goh BC, Shimasaki N. Phase I study of expanded Natural Killer cells in combination with cetuximab for recurrent/metastatic nasopharyngeal carcinoma, Cancer Immunology, Immunotherapy. Jan 2022. Doi: 10.1007/s00262-022-03158-9. Impact factor: 6.968
- Branden Qi Yu Chua, Vanessa Wei Shan Chong, Hanis Binte Abdul Kadir, Brian Sheng Yep Yeo, Pei Yuan Fong M BBS, Isabelle Jia Hui Jang, Chwee Ming Lim. Histopathological Prognostic Factors of Surgically Treated HPV-Associated Oropharyngeal Squamous Cell Carcinoma—A Systematic Review and Meta-analysis", Ann Surg Oncol 29 November 2024, DOI:https://doi.org/10.1245/sl0434-024-16504-1, PMID: 39487900, Impact factor: 5.4
- Ruoyi Hao, Yang Zhang, Zhiqing Tang, Yang Zhou, Lalithkumar Seenivasan, Catherine Po Ling Chan, Jason Ying Kuen Chan, Shuhui Xu, Neville Wei Yang Teo, Kaijun Tay, Vanessa Yee Jueen Tan, Jiun Fong Thong, Kimberley Liqin Kiong, Shaun Loh, Song Tar Toh, Chwee Ming Lim, Hongliang Ren. Upper airway anatomical landmark dataset for automated bronchoscopy and intubation. Scientific Data, Nov 2025. Impact factor: 6.9
- Soon Hwee Ng, Wenjie Huang, Eng Hong Seng, Qimei Ng, Qirong Yang, Su Ming Thean, Wee Ching Ng, Kwok Seng Loh, Joshua K Tay, Chwee Ming Lim, Wei Yee Wan. Diagnostic Value of Epstein-Barr Virus Immunofluorescence and Enzyme-Immunoassay platforms for detecting IgA antibodies in Nasopharyngeal Cancer in a Singaporean Cohort. Journal of Medical Virology, Dec 2025, impact factor 4.6.